Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Market Research Report -- Global Radiopharmaceuticals Market to Reach $5.5 Billion by 2017


Market Research Report -- Global Radiopharmaceuticals Market to Reach $5.5 Billion by 2017

ROCKVILLE, MD -- (Marketwired) -- 04/09/13 -- MarketResearch.com has announced the addition of the market research report "Nuclear Medicine/Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017" to their product offering.

The global radiopharmaceuticals market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, North America, Japan, the Republic of Korea, and Oceania between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is, however, a major threat for manufacturers.

The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects, radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.

North America is the dominant market for diagnostic radioisotopes with 49% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Covidien, Plc (Ireland), GE Healthcare (U.K.), IBA Group (Belgium), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Siemens Healthcare (PETNET) (Germany).

The stable isotopes market was led by two players -- Cambridge Isotope Laboratories (CIL) (U.S.) and Isotec (Sigma Aldrich) (U.S.) -- in 2012; they jointly contributed more than 90% to the global revenue.

For more information, visit

http://www.marketresearch.com/land/product.asp?productid=7491263&progid=85327

Follow us on Facebook http://www.facebook.com/marketresearchdotcom

Follow us on Twitter http://www.twitter.com/marketresearch_

About Packaged Facts

Packaged Facts is a trusted provider of authoritative consumer market research. For over 30 years, our in-depth research, expert analysis and personalized client support have helped business professionals make the right strategic decisions.

In-depth research...expert analysis.

Our reports are written and edited by analysts with years of professional experience in the industries they now cover. This experience and our time-intensive research methodology result in authoritative analysis that aids the decision-making processes of our clients.

Our reports continue to provide a broad, top-level overview of a market, offering not only important raw data, but also providing the interpretation of those numbers that give the data a truly functional edge for our clients.

The right information...at the right time.

From identifying the effects of emerging markets across major industries, to covering the trends in niche markets, our reports are timely. Our editorial team tracks the trends that will shape these markets in the coming months, and years. Packaged Facts provides the expert analysis our clients have come to rely on to make the right strategic decisions, at the right time.

About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit http://www.marketresearch.com.

Contact: Cindy Frei MarketResearch.com 240.747.3014 press@marketresearch.com

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement